Sidijec AQ Injection
Marketer
Sai Parenterals Limited
Salt Composition
Diclofenac (75mg/ml)
Overview Sidijec AQ Injection
Aqueos Sidijec injection offers analgesia, effectively managing pain, inflammation, rigidity, and articular discomfort associated with rheumatoid arthritis, osteoarthritis, and acute musculoskeletal trauma. Parenteral administration is indicated when oral routes are infeasible. This injectable medication must be administered by a qualified healthcare provider; self-injection is strictly prohibited. Prior heart conditions or stroke history should be disclosed to your physician. Report any injection site reactions—such as pain, edema, or erythema—immediately. Common adverse effects include nausea, emesis, cephalalgia, and local injection site reactions. Prolonged therapy may necessitate regular monitoring of renal and hepatic function, along with blood counts. Chronic use carries potential risks of gastrointestinal hemorrhage and nephrotoxicity.
Primary Ingredients of Sidijec AQ Injection
No text provided to rephrase.
Uses of Sidijec AQ Injection
Analgesia
Major Benefits of Sidijec AQ Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Sidijec AQ Injection:
- Injection site reactions (pain, swelling, redness)
- Vomiting
- Flatulence
- Edema (swelling)
- Nausea
- Headache
- Dizziness
How to use Sidijec AQ Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Sidijec AQ Injection works:
Sidijec AQ Injection is a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of specific inflammatory mediators, thus alleviating pain and reducing associated redness and swelling.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Sidijec AQ Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Administering Sidijec AQ Injection during pregnancy is contraindicated due to confirmed risks to fetal development. Nevertheless, in exceptional life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the hazards. Patient consultation with their physician is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Sidijec AQ Injection while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Administering Sidijec AQ Injection may impair driving ability due to potential adverse reactions.
KidneyCAUTION
Caution is advised when administering Sidijec AQ Injection to individuals with impaired renal function. Dosage modification of Sidijec AQ Injection might be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should receive Sidijec AQ Injection with close monitoring. Dosage modification of Sidijec AQ Injection may be necessary; physician consultation is advised.
What if you forget to take Sidijec AQ Injection :
Omit a Sidijec AQ Injection dose? Seek your physician's advice.
Facts to Know About Sidijec AQ Injection
| Label | Value |
|---|---|
| Chemical Category | Phenylacetic Acid Analog |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |



